Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anytime brother doogi
Big boys gonna be running the snot out of several REAL OTC DEALS before this game changing year in the markets is over!!!
Monroe, you hit it on the nose. Carnage is gonna be the name of the game.
11 million share float once this is out of top loss traders hands we should skyrocket over $20.00 and $30.00 ahead. I loved the Goldman Sachs report today it got us alot of attention. It was easy to run over $18.00 pre market I suspect $20.00 plus today should be easy.
AEMD
Hola Pedro buddy! Let's get ready to make the back half of this already game changing year even better than the 1st half has already been right cheers>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Gotta luv having big boy friends who luv these once in a lifetime market landscape times we're all enjoyin' right subs buddy choo-choo;)
Hmmmmmmmmmmmmmmmm well well well subs buddy...that could be a VERY intriguing due dilly find by you thanks my friend:)
Thomas E. Ichim, Ph.D might be the patent holder on the drug.https://exosome-rna.com/aethlon-medical-announces-the-grant-of-a-u-s-patent-protecting-methods-of-capturing-mhc-antigen-associated-exosomes/
You hit a huge Bulls Eye CJ.
by the way just hit you up for 3655
Pay back is hell. I say ... pile it on and send them down the tube as they say in some places which means straight to ....
Exactly Monroe very well said!
Now if we can just take over the FDA. How corrupt they always have been. COVID has make many aware and the pressure is on for change. When all the smoke clears in a couple years we will look back and see how we survived and came out a better world. The corrupt element has shot themselves in the foot and time will tell this story.
Hi Monroe. That is an absolute FACT! We didn't tell them to short lol. That is just too bad for them. The risk they took and now pies in their faces
Yep, we've taken over Wall Street for good now Monroe choo-choo;)
Big boy trading desks taking direction from joe retailers folks!
Shorts here got absolutely slaughtered. Carnage is not over either.
I WANNA ROCK \m/
ALL ABOARD>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
I think for the most part we will with dips and valleys :)
This stock is scary. Goes up fast goes down fast.
I like it!
Yesterday
..I was watching Cramer and the the market after hours and mainly just watching the ticker...I like cheap shares and I saw AEMD keep floating by and it was up about 100%...I knew nothing about the company..I am a self confessed market junkie...So I decided to take a flier and bought 1000 shares...
Later I did some DD on Yahoo Fin and was not very impressed...Even though I am a retired MD...I was having trouble deciphering exactly what AEMD blood sweeper was doing...I woke up several hours ago and OMG the thing was up like Gamestop...
Whether or not this is the real McCoy remains to be seen...But for the near term I plan on holding on for awhile..We should be in for some real action as the company has less than 20 mil shares,,And that can pre stage a real lift off caused by liquidity issues..Like chasing Unicorns...
Moral...Luck trumps skill....
":>} JL
AEMD has such a tiny float imagine what we can see today after what we already saw pre market.
$AEMD is screaming for the top as retail investors work to push a short squeeze following the release of positive COVID data. https://cnafinance.com/aethlon-medical-aemd-stock-heres-why-its-climbing/
i don't think so. wow spike pre-market big mistake my friend
good morning ah wow spike overnight 'Aethlon Medical, Inc. (AEMD)'
Aethlon Medical Inc (AEMD)
1.72 ? 0.0 (0.00%)
Volume: 6,296 @05/26/21 11:26:21 AM EDT
Bid Ask Day's Range
1.71 1.72 1.7138 - 1.75
AEMD Detailed Quote
Aethlon Medical Inc (AEMD)
1.77 ? -0.1 (-5.35%)
Volume: 126,086 @04/16/21 7:37:29 PM EDT
Bid Ask Day's Range
1.73 2.8 1.77 - 1.83
AEMD Detailed Quote
Aethlon Medical Inc (AEMD)
2.63 ? 0.02 (0.77%)
Volume: 245,981 @02/19/21 7:58:07 PM EST
Bid Ask Day's Range
2.58 2.63 2.58 - 2.6822
AEMD Detailed Quote
Dilution monster
$AEMD nice gainer
$AEMD doesn't hold gains @ closing always down from pre-market
sell on da news
'Aethlon Medical, Inc. (AEMD)'
* * $AEMD Video Chart 12-16-2020 * *
Link to Video - click here to watch the technical chart video
Three stocks jumped up today more thank 85%
Thomas Ichim behind all three
Ichim invented cancer use for Aethlon http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=20&f=G&l=50&co1=AND&d=PTXT&s1=ichim.INNM.&OS=IN/ichim&RS=IN/ichim
Ichim is CELZ
Ichim is TSOI
I cashed out premarket and patiently waiting for this to tank to buy back in. I love me some AEMD
Good luck today if you're in.
Be careful -- a large block is being dumped today.
Made a quick profit pre-market
$AEMD Recent Trades - Last 10 of 48744
Time ET Ex Price Change Volume
09:03:11 Q 3.26 1.64 50
09:03:11 Q 3.26 1.64 499
09:03:11 Q 3.25 1.63 100
09:03:11 Q 3.26 1.64 25
09:03:11 Q 3.26 1.64 500
09:03:11 Q 3.26 1.64 100
09:03:11 Q 3.25 1.63 500
09:03:11 Q 3.26 1.64 50
09:03:11 Q 3.26 1.64 200
09:03:11 Q 3.26 1.64 500
READINGS GOOD DIS MORNING $AEMD HUGE MOVER
$AEMD SEC Filings
FORM TYPE RECEIVED PERIOD END DATE REPORT
8-K 12/10/2020 12/07/2020 PDFRTFHTMLXLS
4 11/03/2020 10/30/2020 PDFRTFHTMLXLS
8-K 11/03/2020 10/30/2020 PDFRTFHTMLXLS
10-Q 10/28/2020 09/30/2020 PDFRTFHTMLXLS
8-K 10/28/2020 10/28/2020 PDFRTFHTMLXLS
4 10/01/2020 09/30/2020 PDFRTFHTMLXLS
4 10/01/2020 09/30/2020 PDFRTFHTMLXLS
4 10/01/2020 09/30/2020 PDFRTFHTMLXLS
4 10/01/2020 09/30/2020 PDFRTFHTMLXLS
4 10/01/2020 09/30/2020 PDFRTFHTMLXLS
$AEMD to address bioterror and pandemic threats. The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.
The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and
plasma membrane technology to create therapeutic filtration devices that selectively target the removal
of harmful particles from the entire circulatory system.
Our lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes.
In human studies, Hemopurifier therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs.
We are now focused on advancing our Hemopurifier as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens.
Based on studies conducted by government and non-government research organizations, the Hemopurifier is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats.
$AEMD AETHLON MEDICAL, INC.
9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
http://www.aethlonmedical.com
(858) 459-7800
info@aethlonmedical.com
$AEMD Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck CancerPR NEWSWIRE | 12/16/2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive OfficerPR NEWSWIRE | 11/03/2020
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate UpdatePR NEWSWIRE | 10/28/2020
MORE
Nasdaq
DAILY ADVANCERS
Followers
|
235
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
18494
|
Created
|
11/19/04
|
Type
|
Free
|
Moderators |
At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses,
the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies.
The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure cloaks these targets from immune detection.
At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc.,
a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical,
is focused on the discovery of exosomal biomarker candidates to diagnose and monitor life-threatening diseases.
The proprietary Enzyme-Linked Lectin-Specific Assay (ELLSA™) serves as a platform to isolate exosomal biomarkers from a wide-range of bodily fluids.
In preliminary studies, ELLSA™ demonstrated the ability to isolate exosomes from urine, which resulted in high-sensitivity detection of HIV-infection.
Specific to neurological disorders, Exosome Sciences discovered TauSome™, an exosomal biomarker that may be the first non-invasive candidate to
detect Chronic Traumatic Encephalopathy (CTE) in living individuals. In a study of former National Football League (NFL) players,
TauSome levels were found to be significantly higher as compared to athlete control subjects who participated in non-contact sports.
TauSome levels also correlated with cognitive decline based standardized tests of memory and psychomotor speed. Visit www.exosomesciences.com for additional details.
Time Magazine named the Hemopurifier® a "Top 25 Invention" and a "Remarkable Advance in Healthcare" based on its use in treating Ebola virus.
Emerging pathogens pose a significant threat to mankind. Of the hundreds of viral pathogens known to be infectious to man, only a few are addressed with
proven antiviral drug or vaccine therapies. Beyond the looming threat of bioterrorism, a proliferation of international travel, urban crowding and global warming
is expected to accelerate the emergence of future pandemics. In response, the U.S. Department of Health and Human Services (HHS) has established an initiative
to support platform technology medical countermeasures with broad-spectrum capabilities. Based on preclinical studies and human treatment experiences, the Aethlon Hemopurifier® defines this initiative.
To date, Hemopurifier therapy has been administered to individuals infected with Ebola virus, Hepatitis C virus (HCV) and the Human Immunodeficiency virus (HIV).
In the case of Ebola, a remarkable response to a single administration of Hemopurifier therapy (comatose physician with multiple organ failure at the time), led to
Time Magazine naming the Hemopurifier to be one of the "Top 25 Inventions" as well as one of the "Eleven Most Remarkable Advances in Healthcare."
Beyond human treatment experiences, pre-clinical Hemopurifier studies have validated the broad-spectrum capture of numerous viral threats.
These include: Chikungunya, Dengue and West Nile virus, as well as Vaccinia and Monkey pox, which serve as models for human Smallpox infection.
Specific to pandemic influenza threats, Aethlon has validated the capture of H5N1 avian flu, H1N1 swine flu, and the reconstructed 1918 influenza virus,
which represents a model for the strain of influenza that killed an estimated 50 million victims in 1918 and 1919. In vitro studies of other viral threats are ongoing.
https://coronavirus.jhu.edu/map.html
================================================================================================================================================================================
================================================================================================================================================================================
================================================================================================================================================================================
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |